“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2020-ACL-AOA-DASG-0364, application deadline September 7, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=322431
A. “Impact of Alcohol on the Onset and Progression of Alzheimer’s Disease and Its Related Dementias (R01 – Clinical Trial Optional),” (RFA-AA-20-006, National Institute on Aging, in conjunction with other agencies, application deadline March 24, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-006.html
B. “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (RFA-NS-19-043, National Institute on Aging, in conjunction with other agencies, application deadlines New February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022 Resubmission March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required),” (RFA-NS-19-044).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-043.html
A. “2020 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2020-ACL-AOA-FPSG-0367, application deadline January 31, 2020).
www.grants.gov/web/grants/view-opportunity.html?oppId=322351
B. “2020 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs,” (HHS-2020-ACL-AOA-CSSG-0366, application deadline January 29, 2020).
C. “2020 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs,” (HHS-2020-ACL-AOA-CSSG-0365, application deadline January 29, 2020).
“Leadership Award for Alzheimer’s Disease and Related Dementias Research (R35 Clinical Trial Not Allowed),” (RFA-AG-21-007, National Institute on Aging, application due data June 19, 2020).
A. “Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not Allowed),” (RFA-AG-20-027, National Institute on Aging, application deadline February 3, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-027.html
B. “A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trials Optional),” (RFA-AG-20-026, National Institute on Aging, application deadline February 3, 2020).
“Support of Competitive Research (SCORE) Research Advancement Award (SC1 – Clinical Trial Not Allowed),” (PAR-20-039, a reissue of PAR-16-439, National Institute on Aging, in conjunction with other agencies, application deadlines January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022). Note: There are two companion funding announcements associated with this announcement (follow the link under “Companion Funding Opportunity”): “Support of Competitive Research (SCORE) Pilot Project Award (SC2 – Clinical Trial Not Allowed),” (PAR-20-040); and, “Support of Competitive Research (SCORE) Research Continuance Award (SC3 – Clinical Trial Not Allowed),” (PAR-20-041).
“Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed),” (PAR-19-394, a reissue of PAR-17-025, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16).
“Funding for 2020-2023 Older Americans Act Title VI Native American Programs,” (HHS-2020-ACL-TITLEVI-2001, application closing date December 18, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=321645
“Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed),” (PAS-19-391, a reissue of RFA-AG-19-003, National Institute on Aging, application deadlines Feb. 16, June 16, and Oct. 16). Note: There are two companion funding announcements associated with this announcement (follow the link under “Companion Funding Opportunity”): “Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed),” (PAS-19-392); “Small Research Grant Program for the Next Generation of Clinical Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed),” (PAS-19-393).
“Butler-Williams Scholars Program 2020,” (application deadline February 14, 2020).
A. “NIH Blueprint for Neuroscience Research Education Program on Translational Devices (R25 Clinical Trial Not Allowed),” (RFA-NS-20-003, National Institute on Aging, in conjunction with other agencies, application deadline December 16, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-003.html
B. “The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional),” (RFA-OD-19-029, National Institute on Aging, in conjunction with other agencies, applications deadlines November 25, 2019; November 25, 2020, November 26, 2021).
grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-029.html
C. “Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required),” (RFA-AG-20-051, National Institute on Aging, application deadline January 30, 2020). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required),” (RFA-AG-20-050),
“Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed),” (PAR-19-373, National Institute on Aging, in conjunction with other agencies, applications deadlines March 17, 2020; March 17, 2021). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required),” (PAR-19-384).
A. “Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional),” (PAR-19-374, a reissue of PAR-18-296, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-19-374.html
B. “MD-PhD Training Program in Alzheimer’s Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed),” (RFA-AG-20-032, National Institute on Aging, application deadline October 28, 2019).
“Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed),” (PAR-19-372, a reissue of PAR-16-355, National Institute on Aging, in conjunction with other agencies, application deadlines November 6, 2019, November 6, 2020, November 8, 2021).
A. “Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed),” (RFA-NS-20-005, National Institute on Aging, in conjunction with other agencies, application deadline November 15, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-005.html
B. “Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed),” (RFA-NS-20-014, National Institute on Aging, in conjunction with other agencies, application deadline December 3, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-014.html
C. “Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers (U01 Clinical Trial Optional),” (RFA-DK-19-015, a reissue of RFA-DK-14-004, National Institute on Aging, in conjunction with other agencies, application deadline November 7, 2019).
“Limited Competition: Renewals of, and Revisions and Re-submissions to, the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed),” (PAR-19-338, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
A. “Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed),” (PAR-19-338, National Institute on Aging, applications deadlines March 5, June 5, and Nov. 5).
grants.nih.gov/grants/guide/pa-files/PAR-19-338.html
B. “The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed),” (RFA-AG-20-044, National Institute on Aging, application deadline January 21, 2020).
“SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed,” (PAR-19-333, a reissue of PAR-16-027, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, Jan. 5, and April 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed,” (PAR-19-334).
“Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed),” (RFA-AG-20-035, National Institute on Aging, application deadlines October 18, 2019 and October 19, 2020).
“Palliative Care in Home and Community Settings (R01 Clinical Trial Optional),” (PAR-19-321, National Institute of Nursing Research, application deadlines Oct. 5, Feb. 5, and June 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Palliative Care in Home and Community Settings (R21 Clinical Trial Optional),” (PAR-19-320).
A. “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed),” (RFA-AG-20-010, a reissue of RFA-AG-19-017, National Institute on Aging, application deadline Oct. 22, 2019). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required),” (RFA-AG-20-011).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-010.html
B. “Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-20-030, National Institute on Aging, application deadline October 30, 2019).
“Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-19-316, a reissue of PAS-18-187, National Institute on Aging, application deadlines Sept. 5, Jan. 5, and April 5). Note: Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-19-317).
A. “Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional),” (PAR-19-315, National Institute on Aging, in conjunction with other agencies, application deadlines September 4, 2019; February 14, 2020; July 20, 2020; February 17, 2021; July 19, 2021; and February 14, 2022).
grants.nih.gov/grants/guide/pa-files/PAR-19-315.html
B. “NIA Program Project Applications (P01 Clinical Trial Optional),” (PAR-19-314, a reissue of PAR-18-297 and PAR-18-030, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
“Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional),” (PAR-19-304, National Institute on Aging, application deeadlines Feb. 16, June 16, and Oct. 16). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional),” (PAR-19-305).
“NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required),” (PAR-19-302 , National Institute on Aging, application deadline Feb. 5, June 5, and Oct. 5).
“Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional),” (PAR-19-298, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5).
“Alzheimer’s Disease Programs Initiative – Grants to States and Communities,” (HHS-2019-ACL-AOA-ADPI-0360, application deadline August 13, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=316879
“Limited Competition: NIA Genome Center for Alzheimer’s Disease (GCAD) (U54 Clinical Trial Not Allowed),” (PAR-19-288, a reissue of RFA-AG-16-001, National Institute on Aging, in conjunction with other agencies, application deadlines Jan. 25, May 25, and Sept. 25).
“Cognitive Systems Analysis of Alzheimer’s Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed),” (PAR-19-269, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
“National Volunteer Care Corps,” (HHS-2019-ACL-AOA-CCDG-0352, application deadline June 21, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=313323
“Grants to Enhance State Adult Protective Services FY2019,” (HHS-2019-ACL-AOA-EJSG-0350, application closing date June 24, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=313082
A. “BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed),” (RFA-MH-20-120, National Institute on Aging, in conjunction with other agencies, application deadlines September 6, 2019 and June 11, 2020).
grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-120.html
B. “BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed),” (RFA-MH-20-135, National Institute on Aging, in conjunction with other agencies, application deadlines September 27, 2019 and September 30, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-135.html
C. “Building Interdisciplinary Research Careers in Women’s Health (BIRCWH); K12 Clinical Trial Optional,” (RFA-OD-19-020, National Institute on Aging, in conjunction with other agenices, applicaiton deadline May 29, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-020.html
D. “Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed),” (PAR-19-249, National Institute on Aging, in conjunction with other agencies, application deadlines July 8, 2019; November 4, 2019; March 9, 2020; July 7, 2020; November 9, 2020; and March 8, 2021).
grants.nih.gov/grants/guide/pa-files/PAR-19-249.html
E. “Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional),” (PAR-19-250, National Institute on Aging, in conjunction with other agencies, application deadlines July 8, 2019, November 4, 2019, March 9, 2020, July 7, 2020, November 9, 2020, and March 8, 2021).
“Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed),” (PAR-19-239, National Institute of Dental and Craniofacial Research, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed),” (PAR-19-240).
“Limited Competition: Additional Sequencing for the Alzheimer’s Disease Sequencing Project (U01 Clinical Trial Not Allowed),” (PAR-19-234, a reissue of PAR-16-406, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5).
“Behavioral and Social Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Optional),” (PA-19-226, National Institute on Aging, application deadline May 6, 2019).
“Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional),” (PA-19-217, National Institute on Aging, in conjunction with other agencies, application deadline May 13, 2019).
A. “Geroscience Approaches to Alzheimer’s Disease (R01 Clinical Trial Not Allowed),” (RFA-AG-20-013, National Institute on Aging, application deadline July 2, 2019). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Geroscience Approaches to Alzheimer’s Disease (R21 Clinical Trial Not Allowed),” (RFA-AG-20-014).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-013.html
B. “Functional Target Validation for Alzheimer’s Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed),” (RFA-NS-19-015), National Institute on Aging, in conjunction with other agency, application deadline May 6, 2019.
grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-015.html
C. “Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed),” (PAS-19-210, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5) .
A. “Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional),” (PA-19-200, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional),” (PA-19-201).
grants.nih.gov/grants/guide/pa-files/PA-19-200.html
B. “Limited Competition: Renewal of the Aging Interventions Testing Program (U01 Clinical Trial Not Allowed),” (RFA-AG-19-030, National Institute on Aging, application deadline May 1, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-030.html
C. “Interventions Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-AG-19-031, National Institute on Aging, application deadline May 1, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-AG-19-031.html
D. “Clinical and Biological Measures of TBI-related dementia including Chronic Traumatic Encephalopathy (CTE) (R01 Clinical Trial Not Allowed),” (RFA-NS-19-026, National Institute on Aging, in conjunction with other agencies, application deadline April 15, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-026.html
E. “Neuropathological Assessment of TBI-related Neurodegeneration and Neurocognitive decline – Center Without Walls (NATBI CWOW) (U54 Clinical Trial Not Allowed),” (RFA-NS-19-030, National Institute on Aging, in conjunction with other agencies, application deadline April 15, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-030.html
F. “Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional),” (PA-19-205, National Institute on Aging, in conjunction with other agencies, application deadline April 8, 2019).
A. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32),” (PA-19-188, a reissue of PA-18-670, National Institute on Aging, in conjunction with other agencies, application deadlines April 8, Aug. 8, and Dec. 8).
grants.nih.gov/grants/guide/pa-files/PA-19-188.html
B. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-19-191, a reissue of PA-18-668, National Institute on Aging, in conjunction with other agencies, application deadlines April 8, Aug. 8, and Dec. 8).
grants.nih.gov/grants/guide/pa-files/PA-19-191.html
C. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30),” (PA-19-192, a reissue of PA-18-673, National Institute on Aging, in conjunction with other agencies, application deadlines April 8, Aug. 8, and Dec. 8).
grants.nih.gov/grants/guide/pa-files/PA-19-192.html
D. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31),” (PA-19-195, a reissue of PA-18-671, National Institute on Aging, in conjunction with other agencies, application deadlines April 8, Aug. 8, and Dec. 8).
grants.nih.gov/grants/guide/pa-files/PA-19-195.html
E. “Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31),” (PA-19-196, a reissue of PA-18-666, National Institute on Aging, in conjunction with other agencies, application deadlines April 8, Aug. 8, and Dec. 8).
“Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33),” (PA-19-187, a reissue of PA-18-672, National Institute on Aging, in conjunction with other agencies, funding deadlines April 8, Aug. 8, and Dec. 8).
“Tribal Long Term Services and Supports Resource Center,” (HHS-2019-ACL-AOA-IELT-0349, application deadline May 15, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=312880
“Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed),” (RFA-NS-19-012, National Institute on Aging, in conjunction with other agencies, application deadline April 17, 2019).
“Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed),” (RFA-OD-19-016, National Institute on Aging, in conjunction with other agencies, application deadline March 14, 2019). Note: There are three related funding announcements (follow the link under “Companion Funding Opportunity”): “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required),” (RFA-OD-19-018); and, “INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed),” (RFA-OD-19-015).
“Human Three-Dimensional Cell Model Systems for Alzheimer’s Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed),” (RFA-NS-19-027, National Institute on Aging, in conjunction with other agencies, application deadline March 14, 2019).
A. “Development and Validation of Advanced Mammalian Models for Alzheimer’s: Disease-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed),” (PAR-19-167, National Institute on Aging, in conjunction with other agencies, application deadline March 14, 2019).
grants.nih.gov/grants/guide/pa-files/PAR-19-167.html
B. “Progression Markers for Cognitive Impairment in Parkinson’s Disease Dementia (R01 Clinical Trial Not Allowed),” (PAR-19-170, National Institute on Aging, in conjunction with other agencies, application deadline March 8, 2019).
“Innovations in Nutrition Programs and Services,” (HHS-2019-ACL-AOA-INNU-0345, May 28, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=312013
“Administrative Supplement for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional),” (PA-19-165, a reissue of PA-18-658, National Institute on Aging, in conjunction with other agencies, application deadline February 20, 2019).
A. “Bioengineering Research Grants (BRG) (R01 Clinical Trial Required),” (PAR-19-159, a reissue of PAR-18-206, National Institute on Aging, in conjunction with other agencies, applications deadlines Feb. 5, June 5, and Oct. 5). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed),” (PAR-19-158).
grants.nih.gov/grants/guide/pa-files/PAR-19-159.html
B. “Bioengineering Research Partnerships (U01 Clinical Trial Required),” (PAR-19-157, a reissue of PAR-18-208, National Institute on Aging, in conjunction with other agencies, applications deadlines Feb. 5, June 5, and Oct. 5). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed),” (PAR-19-156).
“Legal Assistance Enhancement Program,” (HHS-2019-ACL-AOA-LAEP-0344, application deadline April 29, 2019).
www.grants.gov/web/grants/view-opportunity.html?oppId=311839
A. “Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed),” (RFA-EB-18-004, National Institute on Aging, in cojunction with other agencies, application deadline February 22, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-EB-18-004.html
B. “NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed),” (RFA-OD-19-014, a reissue of RFA-OD-14-005, National Institute on Aging, in cojunction with other agencies, application deadline March 19, 2019).
grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-014.html
C. “Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required),” (PA-19-116, a reissue of PA-18-372, National Institute on Aging, in cojunction with other agencies, application deadlines March 12, July 12, and Nov. 12). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed),” (PA-19-117).
grants.nih.gov/grants/guide/pa-files/PA-19-116.html
D. “Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required),” (PA-19-118, reissue of PA-18-374, National Institute on Aging, in cojunction with other agencies, application deadlines March 12, July 12, and Nov. 12). Note: There is a related funding announcement (follow the link under “Companion Funding Opportunity”): “Mentored Patient-Oriented Research Career Development Award (Parent K23 – Independent Clinical Trial Not Allowed),” (PA-19-119).
Powered by WordPress
